Central sleep apnea in stable methadone maintenance treatment patients

Chest

Volumn 128, Issue 3, 2005, Pages 1348-1356

  Wang, David ^a   Teichtahl, Harry ^a   Drummer, Olaf ^b   Goodman, Cathy ^a   Cherry, Gaye ^a   Cunnington, David ^a   Kronborg, Ian ^a  

^a WESTERN HOSPITAL   (Australia)

^b VICTORIAN INSTITUTE OF FORENSIC MEDICINE   (Australia)

Author keywords

Central sleep apnea; Hypercapnic ventilatory response; Hypoxic ventilatory response; Methadone

Indexed keywords

ANTIDEPRESSANT AGENT; DIAMORPHINE; METHADONE; MU OPIATE RECEPTOR AGONIST;

ADULT; ARTERIAL CARBON DIOXIDE TENSION; ARTICLE; BODY MASS; CENTRAL SLEEP APNEA SYNDROME; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; FEMALE; HEROIN DEPENDENCE; HUMAN; HYPERCAPNIA; HYPOXIA; LUNG ALVEOLUS OXYGEN TENSION; LUNG VENTILATION; MALE; METHADONE TREATMENT; PATHOGENESIS; POLYSOMNOGRAPHY; PRIORITY JOURNAL;

EID: 24944493973     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.128.3.1348     Document Type: Article

References (58)

1. NIH Consensus Conference. Effective medical treatment of opiate addiction. National Consensus Development Panel on Effective Medical Treatment of Opiate Addiction. JAMA 1998; 280:1936-1943
2. Caplehorn JRM, Batey RG. Methadone maintenance in Australia. J Drug Issues 1992; 22:661-678
3. Ministerial Council on Drug Safety. National background plan on illicit drugs, 2001 to 2002-2003; background paper. Canberra, Australia, 2001; 34
4. Caplehorn JR, Dalton MS, Cluff MC, et al. Retention in methadone maintenance and heroin addicts' risk of death. Addiction 1994; 89:203-209
5. Zador D, Sunjic S, Basili H. All-cause mortality rate and risk of dying in methadone maintenance treatment in New South Wales in 1990-95. International Opioid Overdose Symposium. Sydney, Australia: National Drug and Alcohol Research Centre, 1997
6. Caplehorn JR. Deaths in the first two weeks of maintenance treatment in NSW in 1994: identifying cases of iatrogenic toxicity. Drug Alcohol Rev 1998; 17:9-17
7. White JM, Irvine RJ. Mechanisms of fatal opioid overdose. Addiction 1999; 94:961-972
8. Caplehorn JR, Drummer OH. Mortality associated with New South Wales methadone programs in 1994: lives lost and saved. Med J Aust 1999; 170:104-109
9. Gutstein H, Akil H, eds. Opioid analgesics. New York, NY: McGraw-Hill, 2001
10. Bailey PL, Stanley TH. Intravenous opioid anesthetics. In: Miller RD, ed. Anesthesia. New York, NY: Churchill Livingston, 1994; 291-389
11. Weil JV, McCullough RE, Kline JS, et al. Diminished ventilatory response to hypoxia and hypercapnia after morphine in normal man. N Engl J Med 1975; 292:1103-1106
12. Berkenbosch A, Teppema LJ, Olievier CN, et al. Influences of morphine on the ventilatory response to isocapnic hypoxia. Anesthesiology 1997; 86:1342-1349
13. Bailey PL, Lu JK, Pace NL, et al. Effects of intrathecal morphine on the ventilatory response to hypoxia. N Engl J Med 2000; 343:1228-1234
14. Wingkun JG, Knisely JS, Schnell SH, et al. Decreased carbon dioxide sensitivity in infants of substance-abusing mothers. Pediatrics 1995; 95:864-867
15. Ward SL, Bautista D, Chan L, et al. Sudden infant death syndrome in infants of substance-abusing mothers. J Pediatr 1990; 117:876-881
16. Ward SL, Bautista DB, Woo MS, et al. Responses to hypoxia and hypercapnia in infants of substance-abusing mothers. J Pediatr 1992; 121:704-709
17. Teichtahl H, Prodromidis A, Miller B, et al. Sleep-disordered breathing in stable methadone programme patients: a pilot study. Addiction 2001; 96:395-403
18. Farney RJ, Walker JM, Cloward TV, et al. Sleep-disordered breathing associated with long-term opioid therapy. Chest 2003; 123:632-639
19. Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991; 14:540-545
20. AASM Task Force. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement technique in clinical research. Sleep 1999; 22:667-689
21. American Sleep Disorders Association. EEG arousals: scoring rules and examples; a preliminary report from the Sleep Disorders Atlas Task Force of the American Sleep Disorders Association. Sleep 1992; 15:173-184
22. Rebuck AS, Campbell EJ. A clinical method for assessing the ventilatory response to hypoxia. Am Rev Respir Dis 1974; 109:345-350
23. Read DJ. A clinical method for assessing the ventilatory response to carbon dioxide. Australas Ann Med 1967; 16: 20-32
24. Prisk GK, Elliott AR, West JB. Sustained microgravity reduces the human ventilatory response to hypoxia but not to hypercapnia. J Appl Physiol 2000; 88:1421-1430
25. Shaw RA, Schonfeld SA, Whitcomb ME. Progressive and transient hypoxic ventilatory drive tests in healthy subjects. Am Rev Respir Dis 1982; 126:37-40
26. Drummer OH, Horomidis S, Kourtis S, et al. Capillary gas chromatographic drug screen for use in forensic toxicology. J Anal Toxicol 1994; 18:134-138
27. Teichtahl H, Wang D, Cunnington D, et al. Cardiorespiratory function in stable methadone maintenance program patients. Addict Biol 2004; 3-4:247-253
28. Siegel S, Castellan NJ. Non parametric statistics for the bahavioral sciences. 2nd ed. New York, NY: McGraw-Hill, 1988
29. Tabachnick B, Fidell L. Using multivariate statistics. 4th ed. Boston, MA: Allyn and Bacon, 2001
30. Portney LG, Watkins MP. Foundations of clinical research applications to practice. Stamford, CT: Appleton & Lange, 1993
31. Bradley TD. Crossing the threshold: implications for central sleep apnea. Am J Respir Crit Care Med 2002; 165:1203-1204
32. Naughton MT. Pathophysiology and treatment of Cheyne-Stokes respiration. Thorax 1998; 53:514-518
33. Bradley TD, Phillipson EA. Central sleep apnea. Clin Chest Med 1992; 13:493-505
34. Bradley TD, McNicholas WT, Rutherford R, et al. Clinical and physiologic heterogeneity of the central sleep apnea syndrome. Am Rev Respir Dis 1986; 134:217-221
35. Eap C, Buclin T, Baumann P. Interindividual variability of the clinical pharmacokinetics of methadone: implications for the treatment of opioid dependence. Clin Pharmacokinet 2002; 41:11503-11593
36. Buttner A, Mall G, Penning R, et al. The neuropathology of heroin abuse. Forensic Sci Int 2000; 113:435-442
37. Manchanda S, Connolly MJ. Cerebral infarction in association with Ecstasy abuse. Postgrad Med J 1993; 69:874-875
38. Yen DJ, Wang SJ, Ju TH, et al. Stroke associated with methamphetamine inhalation. Eur Neurol 1994; 34:16-22
39. Perez JA Jr, Arsura EL, Strategos S. Methamphetamine-related stroke: four cases. J Emerg Med 1999; 17:469-471
40. O'Brien CP. Stroke in young women who use cocaine or amphetamines. Epidemiology 1998; 9:587-588
41. Petitti DB, Sidney S, Quesenberry C, et al. Stroke and cocaine or amphetamine use. Epidemiology 1998; 9:596-600
42. Marks CE Jr, Goldring RM. Chronic hypercapnia during methadone maintenance. Am Rev Respir Dis 1973; 108: 1088-1093
43. 2 challenge test. Biol Psychiatry 1998; 43:612-615
44. 2 after clomipramine treatment. Psychiatry Res 1993; 47:295-296
45. Klein DF. False suffocation alarms, spontaneous panics, and related conditions: an integrative hypothesis. Arch Gen Psychiatry 1993; 50:306-317
46. Zwillich CW, Doekel R, Hammill S, et al. The effects of smoked marijuana on metabolism and respiratory control. Am Rev Respir Dis 1978; 118:885-891
47. Gross JB, Blouin RT, Zandsberg S, et al. Effect of flumazenil on ventilatory drive during sedation with midazolam and alfentanil. Anesthesiology 1996; 85:713-720
48. Gerak LR, Brandt MR, France CP. Studies on benzodiazepines and opioids administered alone and in combination in rhesus monkeys: ventilation and drug discrimination. Psychopharmacology (Berl) 1998; 137:164-174
49. Lahiri S, Maret K, Sherpa MG. Dependence of high altitude sleep apnea on ventilatory sensitivity to hypoxia. Respir Physiol 1983; 52:281-301
50. 2 in patients with congestive heart failure. Am J Respir Crit Care Med 2002; 165:1245-1250
51. 2 in sleeping humans. J Physiol 2001; 535:269-278
52. Fatemian M, Kim DY, Poulin MJ, et al. Very mild exposure to hypoxia for 8 h can induce ventilatory acclimatization in humans. Pflugers Arch 2001; 441:840-843
53. Dunai J, Kleiman J, Trinder J. Ventilatory instability during sleep onset in individuals with high peripheral chemosensitivity. J Appl Physiol 1999; 87:661-672
54. Nakayama H, Smith CA, Rodman JR, et al. Effect of ventilatory drive on carbon dioxide sensitivity below eupnea during sleep. Am J Respir Crit Care Med 2002; 165:1251-1260
55. Nakayama H, Smith CA, Dempsey J. Effects of background ventilatory stimuli on the apneic threshold (AT) in sleeping dogs [abstract]. Am J Respir Crit Care Med 2001; 163:A179
56. Ward SL, Schuetz S, Kirshna V, et al. Abnormal sleeping ventilatory pattern in infants of substance-abusing mothers. Am J Dis Child 1986; 140:1015-1020
57. Olsen GD, Lees MH. Ventilatory response to carbon dioxide of infants following chronic prenatal methadone exposure. J Pediatr 1980; 96:983-989
58. Pierson PS, Howard P, Kleber HD. Sudden deaths in infants born to methadone-maintained addicts. JAMA 1972; 220: 1733-1734